Please enable JavaScript or talk to your local administrator to get JavaScript enabled.

Researcher

Hikmat A Al-Ahmadie

Memorial Sloan Kettering Cancer Center, United States

 
4
Projects
USD 9.0 M
Aggregated funding amount
USD 2.2 M
Average funding amount
Projects All >
Sorted by: Start Date
Project list item
Defining the impact of intra-tumoral morphologic, immune and mutational heterogeneity in urothelial carcinoma

National Cancer Institute to HIKMAT AL-AHMADIE

USD 821,670
2019 - 2024
Project list item
Modeling bladder cancer pathogenesis and tumor evolution

National Cancer Institute to CORY ABATE-SHEN, HIKMAT AL-AHMADIE, DAVID B SOLIT, MICHAEL M. SHEN

USD 3,432,927
2018 - 2023
Project list item
SPORE in Bladder Cancer

National Cancer Institute to DEAN F. BAJORIN, TIMOTHY AN-THY CHAN, MICHAEL STEPHEN GLICKMAN, IRINA OSTROVNAYA, HIKMAT AL-AHMADIE, DAVID B SOLIT

USD 4,438,686
2018 - 2023
Project list item
Epigenetic regulation of bladder cancer progression

Bladder Cancer Advocacy Network to Cory Abate-Shen, Michael M Shen, David Brian Solit, Cathy Mendelsohn, Hikmat Al-Ahmadie, James M. McKiernan

USD 300,000
2015 - 2017

Categories FOR (ANZSRC)

All >

Projects

  • 4

    1112 Oncology and Carcinogenesis

  • 1

    1107 Immunology

Categories RCDC

All >

Projects

  • 4

    Biotechnology

  • 4

    Human Genome

  • 4

    Cancer

  • 4

    Genetics

  • 4

    Urologic Diseases

  • 3

    Clinical Research

  • 2

    Immunization

  • 1

    Bioengineering

  • 1

    Clinical Trials and Supportive Activities

  • 1

    Prevention

Categories HRCS HC

All >

Projects

  • 4

    Cancer

Categories HRCS RAC

All >

Projects

  • 3

    2.1 Biological and endogenous factors

  • 2

    5.1 Pharmaceuticals

Categories Health Research Areas

All >

Projects

  • 4

    Biomedical

Categories Broad Research Areas

All >

Projects

  • 2

    Basic Science

  • 2

    Clinical Medicine and Science